Wyeth, Officers To Pay $57M To Settle Securities Class Action Claims

NEW YORK - Wyeth Inc. and several of its executive officers have agreed to pay more than $67 million to settle claims that they misrepresented the safety and approvability of the drug Pristiq in violation of federal securities laws, according to a motion for settlement filed Nov. 9 in New York federal...

Merck To Pay $688M To Settle 2 Securities Class Action Lawsuits

WHITEHOUSE STATION, N.J. - Merck and Co. Inc. will pay $688 million to settle two securities class action lawsuits filed in New Jersey federal court alleging that the drug maker and others failed to disclose adverse results of a clinical trial for two cholesterol drugs Merck was developing, according...